Skip to main content

Perceptive Advisors LLC

SEC CIK
0001224962
Latest filing
Aug 14, 2026

VRDN holding history

Viridian Therapeutics, Inc. in every 13F filed by Perceptive Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRDN overviewAll 13F holders of VRDNFull Q2 2026 holdings

Shares (Q2 2026)
581,980
Value
$10.7M
% of portfolio
0.2%
Quarters held
21
Since Q2 2021
Holdings of VRDN by Perceptive Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026581,980$10.7M0.2%−588,849−50.3%ReducedHolders
Q1 20261,170,829$22.9M0.5%−1,871,874−61.5%ReducedHolders
Q4 20253,042,703$94.7M1.7%+1,580,303+108.1%AddedHolders
Q3 20251,462,400$31.6M0.9%+1,014,893+226.8%AddedHolders
Q2 2025447,507$6.26M0.2%−212,155−32.2%ReducedHolders
Q1 2025659,662$8.89M0.3%−826,846−55.6%ReducedHolders
Q4 20241,486,508$28.5M0.8%−1,326,157−47.1%ReducedHolders
Q3 20242,812,665$64.0M1.4%+1,180,837+72.4%AddedHolders
Q2 20241,631,828$21.2M0.5%−2,025,271−55.4%ReducedHolders
Q1 20243,657,099$64.0M1.1%+1,926,887+111.4%AddedHolders
Q4 20231,730,212$37.7M0.8%+719,007+71.1%AddedHolders
Q3 20231,011,205$15.5M0.5%−765,181−43.1%ReducedHolders
Q2 20231,776,386$42.3M1.2%+40,000+2.3%AddedHolders
Q1 20231,736,386$44.2M1.3%+515,811+42.3%AddedHolders
Q4 20221,220,575$35.7M1.0%00.0%UnchangedHolders
Q3 20221,220,575$25.0M0.7%+248,743+25.6%AddedHolders
Q2 2022971,832$11.2M0.4%−451,221−31.7%ReducedHolders
Q1 20221,423,053$26.3M0.5%00.0%UnchangedHolders
Q4 20211,423,053$28.1M0.4%+530.0%AddedHolders
Q3 20211,423,000$23.4M0.3%+628,494+79.1%AddedHolders
Q2 2021794,506$14.5M0.2%+794,506NewHolders